Episode Details

Back to Episodes
Managing Glaucoma in Pregnancy 2026: Evidence and Consensus

Managing Glaucoma in Pregnancy 2026: Evidence and Consensus

Published 3 months, 3 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/managing-glaucoma-in-pregnancy-2026-evidence-and-consensus

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Managing Glaucoma in Pregnancy 2026: Evidence and Consensus Evidence cutoff: July 24, 2026 Pregnancy does not automatically make glaucoma treatment unsafe, and stopping glaucoma medication without medical supervision can permanently threaten vision. The goal is to protect the pregnant patient’s optic nerve while reducing avoidable exposure of the fetus or breastfed infant to glaucoma medicines. The best available evidence remains limited. There are no large randomized trials of glaucoma treatment during pregnancy. Current recommendations rely on medication labels, animal reproductive studies, pharmacokinetic research, retrospective case series, case reports, and expert consensus. The most current major guidance includes the 2026 American Academy of Ophthalmology Primary Open-Angle Glaucoma Preferred Practice Pattern, the American Glaucoma Society and Canadian Glaucoma Society practical guide, and updated clinical reviews. () > Important: This article is educational and cannot replace individualized care from a glaucoma specialist, obstetric clinician, and—when appropriate—a pediatric or neonatal clinician. Key recommendations at a glance Plan before conception whenever possible. Establish a target pressure, document the optic nerve and visual field, review medications, and consider laser treatment or surgery before pregnancy if glaucoma is advanced or difficult to control. Do not assume that pregnancy will lower pressure enough. Intraocular pressure often falls, but some patients with established glaucoma experience pressure elevation or visual field progression. Use the fewest medicines at the lowest effective exposure. Punctal occlusion and gentle eyelid closure should be used after every drop. Brimonidine is commonly preferred when a glaucoma drop is needed during pregnancy, but it should be stopped before delivery and avoided during breastfeeding because of possible infant central nervous system depression and apnea. Timolol may be used selectively, particularly when the maternal benefit is important, but fetal growth and heart rate should be considered, and newborns may require observation after late-pregnancy exposure. Topical carbonic anhydrase inhibitors such as dorzolamide or brinzolamide are possible alternatives when needed, although human pregnancy and milk data are limited. Oral acetazolamide is generally reserved for serious or refractory pressure elevation. It is often considered acceptable during breastfeeding, but exposure near delivery has occasionally been associated with temporary neonatal metabolic acidosis. Prostaglandin analogues are not first-line during pregnancy because of a theoretical risk of uterine contraction or premature labor and limited human data. Selective laser trabeculoplasty may reduce or eliminate medication exposure. Guidance differs slightly on first-trimester elective treatment, so timing should depend on disease severity and urgency. Incisional surgery is unusual but justified when vision is at meaningful risk. If it cannot be deferred, the second trimester is generally preferred, with local anesthesia and avoidance of antimetabolites whenever possible. How pregnancy changes intraocular pressure Normal physiologic changes Intraocular pressure usually decreases during pregnancy. Proposed explanations include: Increased aqueous humor outflow related to hormonal changes Reduced episcleral venous p

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us